Pasithea Therapeutics (NASDAQ:KTTA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Pasithea Therapeutics (KTTA) operate in?

Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Pasithea Therapeutics Stock (NASDAQ: KTTA) stock price, news, charts, stock research, profile.

Open	$4.11
Close	$3.96
Volume / Avg.	90.66K / 15.70K
Day Range	$3.84 - $4.32
52 Wk Range	3.61 - 17.40
Market Cap	$4.68M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.52%
Days to Cover	1

Recent News

Nasdaq Edges Higher; Macy's Shares Jump

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Monday. The Dow traded up 0.26% to 36,341.44 while the NASDAQ rose 0.12% to 14,421.98. The S&P 500 also rose, gaining, 0.30% to 4,618.11.

Avi Kapoor

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

Avi Kapoor

Dow Surges 100 Points; Cogent Biosciences Shares Plunge

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.28% to 36,349.22 while the NASDAQ fell 0.36% to 14,352.34. The S&P 500 also rose, gaining, 0.06% to 4,607.02.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.11
Close	$3.96
Volume / Avg.	90.66K / 15.70K
Day Range	$3.84 - $4.32
52 Wk Range	3.61 - 17.40
Market Cap	$4.68M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.52%
Days to Cover	1

About Pasithea Therapeutics Corp

Sector

Health Care

Industry

Biotechnology

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pasithea Therapeutics (KTTA) stock?

You can purchase shares of Pasithea Therapeutics (NASDAQ:KTTA) through any online brokerage.

View our list of the best stock brokerages

Who are Pasithea Therapeutics (KTTA) competitors?

Other companies in Pasithea Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and AquaBounty Techs (NASDAQ:AQB).

What is the forecast, or price target, for Pasithea Therapeutics (KTTA) stock?

Pasithea Therapeutics has a consensus price target of $2.00.

What is the current price for Pasithea Therapeutics (KTTA)?

The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $4.4835 last updated September 20, 2024 at 5:52 PM EDT.

Does Pasithea Therapeutics (KTTA) pay a dividend?

There are no upcoming dividends for Pasithea Therapeutics.

When is Pasithea Therapeutics (NASDAQ:KTTA) reporting earnings?

Pasithea Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.

Is Pasithea Therapeutics (KTTA) going to split?

There is no upcoming split for Pasithea Therapeutics.

What sector and industry does Pasithea Therapeutics (KTTA) operate in?

Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Pasithea Therapeutics

Pasithea Therapeutics (KTTA) Forecast

Pasithea Therapeutics (NASDAQ:KTTA) Stock Quotes, Forecast and News Summary

Recent News

Financials

Analyst Rating and Forecast

Compare

FAQ

How do I buy Pasithea Therapeutics (KTTA) stock?

Who are Pasithea Therapeutics (KTTA) competitors?

What is the forecast, or price target, for Pasithea Therapeutics (KTTA) stock?

What is the current price for Pasithea Therapeutics (KTTA)?

Does Pasithea Therapeutics (KTTA) pay a dividend?

When is Pasithea Therapeutics (NASDAQ:KTTA) reporting earnings?

Is Pasithea Therapeutics (KTTA) going to split?

What sector and industry does Pasithea Therapeutics (KTTA) operate in?

People Also Watch